Evaluation of the symbol digit modalities test (SDMT) and MS neuropsychological screening questionnaire (MSNQ) in natalizumab-treated MS patients over 48 weeks

S.A. Morrow, P.W. O'Connor, C.H. Polman, A.D. Goodman, L. Kappos, F.D. Lublin, R.A. Rudick, S. Jurgensen, D. Paes, F. Forrestal, R.H.B. Benedict

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)1385-1392
JournalMultiple Sclerosis
Issue number11
Publication statusPublished - 2010

Cite this